eslicarbazepine love

eslicarbazepine

Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. S-licarbazepine, an active metabolite of oxcarbazepine.

Etymologies

Sorry, no etymologies found.

Examples

  • Sepracor acquired the rights to commercialize eslicarbazepine acetate in the U.S. and Canadian markets from BIAL in late 2007.

    Medlogs - Recent stories

  • BIAL-Portela & Ca, S.A. (BIAL), a privately held Portuguese pharmaceutical company, was responsible for the research and development of eslicarbazepine acetate.

    Medlogs - Recent stories

  • During the trials, patients were randomized to eslicarbazepine acetate or placebo, and after a two-week titration period, were assessed over a 12-week maintenance period with continued follow-up over a one-year, open-label period.

    Medlogs - Recent stories

  • Sepracor Inc. today announced that clinical study data for STEDESA ™ (eslicarbazepine acetate) will b ...

    THE MEDICAL NEWS

  • SEP-2093 eslicarbazepine acetate for the adjunctive treatment of Epilepsy.

    Healthcare Sector and Stocks Analysis from Seeking Alpha

  • In early 2008 we announced the in-licensing of the eslicarbazepine acetate from Bial and we entered into the exclusive U.S. marketing and development agreement with Nycomed, for OMNARIS and ALVESCO brands of ciclesonide.

    SeekingAlpha.com: Home Page

  • In addition, obviously we are very focused on putting in the NDA for eslicarbazepine acetate to the FDA in the early part of next year.

    SeekingAlpha.com: Home Page

  • We also remain on track to submit our new drug application for eslicarbazepine acetate, a new anti-epileptic early next year.

    SeekingAlpha.com: Home Page

  • This acquisition establishes a commercial platform from which we plan to potentially launch in Canada, such products as LUNESTA, BROVANA, eslicarbazepine acetate and other potential products from the Sepracor R&D portfolio.

    SeekingAlpha.com: Home Page

  • We have successfully completed several corporate development and licensing agreements, in particular in licensing eslicarbazepine acetate from Bial, the Nycomed agreement, the Arrow agreements and the acquisition of Oryx in Canada.

    SeekingAlpha.com: Home Page

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.